The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alternative biweekly dosing schedule of trifluridine-tipiracil (TAS-102) reduces rates of myelosuppression while maintaining therapeutic efficacy in patients (pts) with previously treated metastatic colorectal cancer (mCRC).
 
Christopher G Cann
Consulting or Advisory Role - Curio Science; Targeted Oncology
 
Sarah Cimino
No Relationships to Disclose
 
Brian Grieb
No Relationships to Disclose
 
Kristen Keon Ciombor
Consulting or Advisory Role - Array BioPharma; Bayer; Foundation Medicine; Lilly; Merck; Natera; Pfizer; Replimune; Research to Practice; Seagen; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Pfizer/Calithera (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Array BioPharma
 
Rajiv Agarwal
Honoraria - ASCO
Travel, Accommodations, Expenses - Ipsen
 
Satya Das
Honoraria - Ipsen; Novartis; Tersera
Research Funding - Exelixis
 
Laura Williams Goff
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Exelixis; Genentech; Merck; QED Therapeutics
Research Funding - Agios; ASLAN Pharmaceuticals; Basilea; BeiGene; Bristol-Myers Squibb; Merck (Inst)
 
Dana Backlund Cardin
Honoraria - OncLive/MJH Life Sciences
Consulting or Advisory Role - Clarivate; Rafael Pharmaceuticals
Research Funding - Array BioPharma (Inst); Celgene (Inst); Corcept Therapeutics (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Rafael Pharmaceuticals (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - ipsen
 
Shemeka Davis
No Relationships to Disclose
 
Casey Fletcher
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Bayer Health; Clovis Oncology; insmed; ipsen; Mirati Therapeutics; qed therapeutics
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Atreca (Inst); Bayer (Inst); boston biomedical (Inst); Bristol-Myers Squibb/Celgene (Inst); Day One Biopharmaceuticals (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); I-MAB (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); pfizer (Inst); PsiOxus Therapeutics (Inst)
Travel, Accommodations, Expenses - boston Biomedical
Other Relationship - Karyopharm Therapeutics; novocure; Pancreatic Cancer Action Network
 
Cathy Eng
Consulting or Advisory Role - Bayer Health; Gilead/Forty Seven; GlaxoSmithKline; Hookipa Biotech; Mirati Therapeutics; natera; Pfizer
Research Funding - Elevar Therapeutics; Hutchison China Meditech; Merck; Pfizer